cytarabine has been researched along with Thrombopenia in 147 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 64 (43.54) | 18.7374 |
| 1990's | 22 (14.97) | 18.2507 |
| 2000's | 32 (21.77) | 29.6817 |
| 2010's | 26 (17.69) | 24.3611 |
| 2020's | 3 (2.04) | 2.80 |
| Authors | Studies |
|---|---|
| Badillo, M; Fayad, L; Feng, L; Flowers, CR; Fowler, N; Hagemeister, FB; Hill, HA; Iyer, SP; Jain, P; Jorgensen, J; Kanagal-Shamanna, R; Lee, HJ; Li, S; Lin, P; Medeiros, LJ; Nair, R; Nastoupil, L; Navsaria, L; Nogueras Gonzalez, GM; Ok, CY; Patel, KP; Samaniego, F; Santos, D; Steiner, R; Tang, G; Thirumurthi, S; Vega, F; Wagner-Bartak, N; Wang, L; Wang, ML; Wang, SA; Westin, JR; Xu, G; Xuelin, H; Yao, Y; Yin, CC; Zhao, S | 1 |
| Cruickshank, A; Koury, J | 1 |
| Bakare, BY; Bello, FO; Ojo, OT; Olatunji, AO; Olatunji, PO | 1 |
| Shi, T; Xie, W; Yang, X; Ye, X; Zhao, S; Zhu, J; Zhu, L | 1 |
| Bomalaski, JS; Chen, TY; Cho, SF; Feng, X; Hsiao, HH; Hsu, YT; Johnston, A; Kao, HW; Kuo, MC; Liu, TC; Liu, YC; Tsai, HJ | 1 |
| Bussel, J; Soff, J | 1 |
| Arnall, J; Griffin, S; Hargett, C; Hatley, C; Hill, H; Howell, T; Janes, A; Larck, C; Park, S; Swift, K | 1 |
| Amores-Fuster, I; Blackwood, L; Elliott, J; Finotello, R; Grant, IA; Harper, A; Killick, DR; Marrington, M; Mas, A; Smallwood, K; Tanis, JB | 1 |
| Dailey, ME; Gorgan, MA; Mar, N; Vredenburgh, JJ | 1 |
| Adès, L; Ame, S; Beyne-Rauzy, O; Braun, T; Charbonnier, A; Delaunay, J; Dreyfus, F; Fenaux, P; Prebet, T; Raffoux, E; Stammatoullas, A; Vey, N; Wattel, E | 1 |
| Barr, PM; Caimi, PF; Carson, KR; Evens, AM; Gordon, LI; Gregory, SA; Helenowski, I; Islam, N; Jovanovic, B; Kolesar, J; Nabhan, C | 1 |
| Castaigne, S; Farhat, H; Garcia, I; Ghez, S; Merabet, F; Pilorge, S; Preudhomme, C; Rabian, F; Raggueneau, V; Renneville, A; Rigaudeau, S; Rousselot, P; Sarkozy, C; Taksin, AL; Terré, C | 1 |
| Bai, B; Cai, QC; Cai, QQ; Gao, Y; Huang, HQ; Jiang, WQ; Wang, XX; Xia, YF; Xia, ZJ | 1 |
| Cao, XM; Chen, YX; Gu, LF; He, AL; Lei, B; Liu, J; Ma, XR; Wang, FX; Wang, J; Wang, JL; Xu, Y; Yang, Y; Zhang, PY; Zhang, WG; Zhao, WH | 1 |
| De Castro, CM; Griffin, PT; Komrokji, RS; Lancet, JE; List, AF; Melchert, M; Rizzieri, DA | 1 |
| Bai, CX; Wang, HY; Wang, QC; Zhu, XH | 1 |
| Gillem, J; Giuffrida, M; Krick, E | 1 |
| Ambrosetti, A; Balzarotti, M; Binder, M; Cavalli, F; Cwynarski, K; Deckert, M; Fabbri, A; Ferrari, A; Ferreri, AJ; Finke, J; Fox, CP; Gørløv, JS; Hemmaway, C; Hertenstein, B; Hess, G; Illerhaus, G; Johnson, P; Keller, U; Krause, SW; Levis, A; Linton, KM; Panse, J; Pisani, F; Politi, LS; Ponzoni, M; Pukrop, T; Pulczynski, E; Reni, M; Rosée, PL; Roth, A; Rudà, R; Schmoll, HJ; Schorb, E; Stilgenbauer, S; Torri, V; Tucci, A; Zucca, E | 1 |
| Chao, Z; Chen, XM; Deng, CX; DU, X; Huang, X; Lai, PL; Li, MM; Liao, PJ; Ling, W; Lu, ZS; Wan, CC; Wang, YL; Weng, JY; Wu, SJ; Zhong, LY; Zou, XL | 1 |
| Liu, HB; Wang, W | 1 |
| Ahn, HK; Chang, MH; Kim, SJ; Kim, WS; Lee, SJ; Yi, JH | 1 |
| Schmiegelow, K; Schroeder, H; van Kooten Niekerk, PB | 1 |
| Canning, C; DeAngelo, DJ; Galinsky, I; Janosova, A; Ritz, J; Soiffer, RJ; Stone, RM | 1 |
| Demir, M; Oztürk, E; Pamuk, GE; Taşçi, M | 1 |
| Huh, J; Kim, BS; Kim, K; Kim, SJ; Kim, WS; Ko, YH; Suh, C | 1 |
| Guan, ZZ; Lin, H; Ling, JY; Luo, WB; Peng, RJ; Sun, XF; Xia, Y; Xiang, XJ; Zhen, ZJ; Zheng, L | 1 |
| Casassus, P; Caulet-Maugendre, S; Celigny, PS; Colombat, P; Colonna, M; Cornillon, J; Corront, B; Damaj, G; Deconinck, E; El Yamani, A; Gressin, R; Gyan, E; Lamy, T; Le Gouill, S; Lepeu, G; Maisonneuve, H; Moles, MP; Rossi, JF; Tournilhac, O; Vilque, JP | 1 |
| Artz, A; Daugherty, CK; Godley, LA; Green, M; Larson, RA; Le Beau, MM; Lin, S; Njiaju, UO; Odenike, O; Rich, ES; Stock, W; Van Besien, K; Weiner, H; Zhang, Y | 1 |
| Geisler, CH | 1 |
| Apibal, S; Banklau, C; Hongeng, S; Jindadamrongwech, S; Paisooksantivatana, K; Pakakasama, S; Sawangpanich, R | 1 |
| Buset, EM; Haile, SR; Honegger, H; Knuth, A; Mischo, A; Pestalozzi, BC; Petrausch, U; Renner, C; Samaras, P; Schanz, U; Siciliano, RD; Stahel, RA; Stenner-Liewen, F; Stussi, G | 1 |
| Allard, C; Berger, M; Berthou, C; Coiteux, V; Corm, S; Delmer, A; Eclache, V; Etienne, G; Gardembas, M; Guerci-Bresler, A; Guilhot, F; Guilhot, J; Jourdan, E; Legros, L; Mahon, FX; Maloisel, F; Nicolini, FE; Preudhomme, C; Rea, D; Rigal-Huguet, F; Roche-Lestienne, C; Rousselot, P; Vekhoff, A | 1 |
| Forsch, S; Janssens, U; Niedeggen, A; Staib, P | 1 |
| Arthur, C; Buckstein, R; Cermak, J; Chou, WC; Delaunay, J; Dmoszynska, A; Faderl, S; Gau, JP; Kantarjian, HM; Kuo, CY; Lysák, D; Mayer, J; Mazur, G; Minden, M; Oriol, A; Ravandi, F; Thomas, XG; Wierzbowska, A | 1 |
| Diehl, V; Dörken, B; Engert, A; Hossfeld, DK; Josting, A; Kirchner, HH; Mapara, M; Reiser, M; Rudolph, C; Sieber, M | 1 |
| Arellano-Rodrigo, E; Bessell, EM; Graus, F; López-Guillermo, A; Montserrat, E; Nomdedeu, B | 1 |
| Go, RS; Johnston, KL | 1 |
| Berthaud, P; Berthou, C; Buzyn, A; Cheron, N; Facon, T; Gardembas, M; Guilhot, F; Guilhot, J; Legros, L; Mahon, FX; Maloisel, F; Michallet, M; Rigal-Huguet, F; Rousselot, P; Tulliez, M; Vigier, M | 1 |
| Andretta, C; Camera, A; Ciancia, R; Della Cioppa, P; Picardi, M; Rinaldi, CR; Rossi, M; Rotoli, B; Selleri, C; Villa, MR; Volpicelli, M | 1 |
| Au, WY; Chan, EC; Kwong, YL; Leung, AY; Liang, R; Lie, AK; Ooi, GC; Siu, LL | 1 |
| Dutcher, JP; Karbasian-Esfahani, M; Novik, Y; Paietta, E; Wiernik, PH | 1 |
| Assari, S; Bennaceur, AL; Boccaccio, C; Bonnet, ML; Bourhis, JH; Decaudin, D; Farace, F; Greissenger, N; Guillier, M; Marracho, MC; Michon, J; Némati, F; Turhan, AG; Vantelon, JM | 1 |
| Goto, A; Ishii, Y; Katagiri, T; Miyazawa, K; Ohyashiki, K | 1 |
| Gou, HF; Hou, M; Li, L; Qiu, M; Yan, X; Zhu, J | 1 |
| Boula, AM; Christoforidou, AV; Foudoulakis, AM; Mantadakis, E; Samonis, G; Xilouri, IM | 1 |
| Chen, FY; Hou, M; Jin, J; Li, JM; Liang, H; Qiu, XF; Qiu, ZC; Shen, Y; Shen, ZX; Song, EY; Song, YP; Wu, DP | 1 |
| Aydin, S; Dührsen, U; Nückel, H | 1 |
| Bartucci, M; De Maria, R; Martinetti, D; Peschle, C; Signore, M; Zeuner, A | 1 |
| Bogdanova, E; Gregory, SA; Harting, R; O'brien, T; Venugopal, P | 1 |
| Chen, YB; Fu, WJ; Hou, J; Wang, DX; Xi, H; Yuan, ZG | 1 |
| Forcier, RJ; LeMarbre, PA; Maurer, LH; O'Donnell, JF; Quinn, BM; Stern, R | 1 |
| Berchtold, W; Cavalli, F; Fopp, M; Gratwohl, A; Imbach, P; Maurice, P; Sauter, C; Tschopp, L; von Fliedner, V | 1 |
| Carpenter, J; Fishkin, E; Krauss, S; Moore, MR; Raab, S; Raney, M; Smalley, RV; Stagg, M; Velez-Garcia, E; Vogel, CL | 1 |
| Lefante, J; Stein, RS; Vogler, WR | 1 |
| De Bock, R; Haanen, C; Jehn, U | 1 |
| Brincker, H; Drivsholm, A; Ellegaard, J; Freund, L; Jensen, KB; Jensen, MK; Nissen, NI; Pedersen-Bjergaard, J | 1 |
| Golomb, HM; Sweet, DL | 1 |
| Flexner, JH; Graber, SE; Stein, RS | 1 |
| Fehr, J; Frick, P; Gmuer, J; Honegger, H; Martz, G; Sauter, C | 1 |
| Khoo, RK; Ng, PR; Todd, D | 1 |
| Büchner, T; Hiddemann, W; Kamanabroo, D; Schulte, H; Urbanitz, D; van de Loo, J | 1 |
| Bendandi, M; Cantagalli, F; Macchi, S; Mancino, A; Simoncelli, F; Stefanati, V; Tura, S; Visani, G; Zaccaria, A; Zinzani, PL | 1 |
| Ben-Shahar, M; Epelbaum, R; Haim, N | 1 |
| Abdel-Warith, A; Berry, J; Ezzat, AA; Khalifa, F; Khan, B; Raja, MA | 1 |
| Damon, LE; Linker, CA; Ries, CA; Rugo, HS | 1 |
| Baker, M; Bhalla, K; Grant, S | 1 |
| Adde, M; Arndt, C; Gootenberg, J; Horak, ID; Jaffe, E; Magrath, I; Neely, J; Nieder, M; Seibel, N; Shad, A; Venzon, D; Wittes, RA | 1 |
| Furukawa, Y; Hagiwara, S; Hatake, K; Hoshino, Y; Iwao, N; Komatsu, N; Shimizu, R; Suzuki, T; Tomizuka, H; Yoshida, M | 1 |
| Baars, JW; de Glas-Vos, CW; Rodenhuis, S; Thomas, BL; van der Lelie, H; van Dijk, MA; van Oers, RH; von dem Borne, AE | 1 |
| Munshi, NC; Tricot, GJ | 1 |
| Campbell, J; De La Serna, J; Diaz-Mediavilla, J; Francisco Tomás, J; García de Paredes, ML; Grande, C; Solano, C | 1 |
| Chen, PM; Chiou, TJ; Hsieh, RK; Liu, JH; Tzeng, CH; Wang, WS; Yen, CC | 1 |
| Feliu, E; Hernández, JA; Millá, F; Navarro, JT; Oriol, A; Pujol, M; Ribera, JM; Sancho, JM | 1 |
| Behringer, D; Köhler, G; Lindemann, A; Lübbert, M; Mertelsmann, R; Würthner, JU | 1 |
| Berinstein, NL; Franssen, E; Haq, R; Sawka, CA | 1 |
| Beran, M; Kantarjian, H | 1 |
| Auclerc, MF; Auvrignon, A; Baruchel, A; Bauduer, F; Berthou, C; Bordigoni, P; Demeocq, F; Lamagnere, JP; Landman-Parker, J; Leblanc, T; Legall, E; Leverger, G; Mathey, C; Michel, G; Pautard, B; Perel, Y; Schaison, G; Schneider, P | 1 |
| Benz, MS; Kramer, D; Murray, TG; Scott, IU; Toledano, S | 1 |
| Abruzzese, E; Amadori, S; Buccisano, F; Cox, MC; Del Poeta, G; Masi, M; Maurillo, L; Scimò, MT; Tamburini, A; Tribalto, M; Venditti, A | 1 |
| Aird, W; Amrein, P; MacNeill, K; Neuberg, D; Shulman, LN; Sternberg, DW; Thompson, L | 1 |
| Ahmed, S; Arlauskas, P; Du, W; Gordon, C; Kellogg, C; Shields, AF; Vaitkevicius, VK; Zalupski, MM | 1 |
| Abgrall, JF; Colombat, P; Cornillet, P; Deconinck, E; Delain, M; Gardembas, M; Kootz, C; Milpied, N; Tourani, JM | 1 |
| Gala, I; Kim, YN; Moster, M; Pleanboonlers, N; Rerkpattanapipat, P; Suwattee, P; Turtz, A; Wongpraparut, N | 1 |
| Bernard, M; Casassus, P; Delain, M; Desablens, B; Guilhot, F; Hunault-Berger, M; Ifrah, N; Jouet, JP; Milpied, N; Sadoun, A | 1 |
| Barcos, M; Bloomfield, CD; Freter, CE; Frizzera, G; Johnson, JL; Lee, EJ; Peterson, BA; Petroni, GR; Schiffer, CA | 1 |
| Fox, RM; Grigg, AP; Seymour, JF; Szer, J | 1 |
| Becker, PS; O'Donnell, J; Quesenberry, PJ; Rossi, HA; Sarcinelli, F; Stewart, FM | 1 |
| Cowall, DE; Trump, DL | 1 |
| Garratty, G; Morel, PA; Ness, PM; Perkins, HA | 1 |
| Ellison, RR | 1 |
| Bodey, GP; Freireich, EM; McCredie, KB; Whitecar, JP | 1 |
| Frei, E; Lokich, JJ; Muss, HB | 1 |
| Abeloff, M; Burke, PJ; Davis, TE; Waterbury, L | 1 |
| Bergmann, OJ; Dahl, M; Ellegaard, B; Ellegaard, J | 1 |
| Bosly, A; De Bruyère, M; Delannoy, A; Deneys, V; Doyen, C; Ferrant, A; Martiat, P; Michaux, JL; Sokal, G; Van den Bossche, L | 1 |
| Hempling, RE; Piver, MS; Sprance, HE | 1 |
| Batist, G; Boos, G; Mulder, D; Shennib, H; Thirlwell, M; Trudeau, M | 1 |
| Albain, KS; Erickson, LC; Fisher, RI; Stiff, PJ; Swinnen, LJ | 1 |
| Cleary, SM; Howell, SB; Kirmani, S; Mowry, J; Zimm, S | 1 |
| Büchner, T; Essink, ME; Hiddemann, W; van de Loo, J; von Eiff, M | 1 |
| Bearden, JD; Capizzi, RL; Jackson, DV; Lyerly, ES; Morgan, TM; Muss, HB; Powell, BL; Richards, F; Rosenbaum, DL; White, DR | 1 |
| Fukutani, H; Hirano, A; Horikoshi, N; Inoue, K; Itami, S; Mizunuma, N; Mukaiyama, T; Ogawa, M; Tabata, M | 1 |
| del Valle, F; Dörken, B; Hiddemann, W; Ho, AD; Hunstein, W; Meusers, P; Rückle, H; Schlimok, G; Schwammborn, J; Thiel, E | 1 |
| Dua, H; Kochupillai, V; Kumar, L | 1 |
| Cousar, JB; Greco, FA; Greer, JP; Hainsworth, JD; Stein, RS; Wolff, SN | 1 |
| Anderson, J; Bloomfield, CD; Cooper, MR; Ginsberg, SJ; Gottlieb, AJ; Hurd, DD; Lachant, NA | 1 |
| Ehninger, G; Freund, M; Heil, G; Hoelzer, D; Kurrle, E; Link, H; Mitrou, PS; Ohl, S; Queisser, W; Schlimok, G | 1 |
| Baquerizo, H; Byrnes, JJ; Gonzalez, M; Hensely, GT | 1 |
| Estey, E; Freireich, EJ; Iacoboni, SJ; Kantarjian, HM; Keating, MJ; McCredie, KB; Plunkett, W | 1 |
| Barnett, MJ; Bragman, K; Dhaliwal, HS; Lister, TA; Malpas, JS; Prentice, HG; Shannon, MS | 1 |
| Bowman, A; Chessells, JM; Holtzel, H; Pinkerton, CR | 1 |
| Griffin, JD; Kufe, DW; Spriggs, DR | 1 |
| Azarnia, N; Barcos, M; Browman, G; D'Arrigo, P; Grunwald, H; Larson, R; Preisler, HD; Raza, A; Stein, A; Walker, I | 1 |
| Arlin, ZA; Berman, E; Chaganti, RS; Clarkson, BD; Gee, T; Jhanwar, SC; Kurland, E; Mertelsmann, R; Moore, MA | 1 |
| Avramis, VI; Biener, R; Ettinger, LJ; Finklestein, JZ; Holcenberg, JS; Jones, GR; Kamalakar, P | 1 |
| Ershler, WB; Roberts, JD; Stewart, JA; Tindle, BH | 1 |
| Ettinger, LJ; Jones, GR | 1 |
| Dabich, L; Ensminger, WD; LoBuglio, AF; Wheeler, RH; Zuckerman, KS | 1 |
| Markman, M | 1 |
| Ito, K; Kobayashi, K; Matsuda, T; Nakagoshi, T; Nakamura, E; Nakamura, S; Nakanishi, J; Natori, K; Ohtake, S; Yoshida, T | 1 |
| Barnett, MJ; Dhaliwal, HS; Gallagher, CJ; Lister, TA; Richards, MA; Rohatiner, AZ; Waxman, JH | 1 |
| Kufe, DW; Robbins, G; Spriggs, DR; Takvorian, T | 1 |
| Atkins, JN; Capizzi, RL; Cooper, MR; Craig, J; Ferree, D; Homesley, HD; Jobson, V; McMahan, RA; Muss, HB; Powell, BL | 1 |
| Anderson, J; Green, MR; Schilsky, RL | 1 |
| Gottlieb, JA | 1 |
| Avery, GB; Kraybill, EN; Movassaghi, N; Sever, JL | 1 |
| Gralnick, HR; Halterman, R; McGinniss, M | 1 |
| Andrews, NC; Davis, HL; Madden, R; Rochlin, DB; Sedransk, N; Weiss, AJ; Wilson, WL | 1 |
| Colebatch, JH; Matthews, RN | 1 |
| Bernard, J; Blom, J; Boiron, M; Brunner, K; Cooper, MR; Cuttner, J; Ellison, RR; Gailani, S; Glidewell, OJ; Haurani, F; Holland, JF; Hoogstraten, B; Jacquillat, C; Levy, R; Lowenstein, L; Nissen, NI; Rege, VB; Serpick, AA; Silver, RT; Wasserman, L; Weil, M; Wiernik, PH | 1 |
| Gjemdal, T; Stavem, P | 1 |
| Albrecht, M; Fülle, HH | 1 |
| Bryan, JH; Henderson, ES; Leventhal, BG | 1 |
| Armentrout, SA; Burns, CP | 1 |
| Bricteux, N | 1 |
| Friedman, IA; Gynn, TN; Messmore, HL | 1 |
| Basch, A; d'Oliveira, JG; Dreyfus, B; Gorius, JB; Sultan, C | 1 |
| Burningham, R; Falkson, G; Gailani, S; Holland, JF; Larsen, V; Leone, L | 1 |
| Dano, K; Nissen, NI | 1 |
| Hurwitz, BS; Walker, MD | 1 |
| Fischer, JJ; Papac, RJ | 1 |
| Armata, J; Cyklis, R; Garwicz, S; Halikowski, B; Wyszkowski, J | 1 |
| Zubrod, CG | 1 |
| Das, L; Dohlwitz, A; Hall, TC; Jaffe, N; Moloney, WC; Traggis, DG | 1 |
| Braunsteiner, H; Schmalzl, F | 1 |
9 review(s) available for cytarabine and Thrombopenia
| Article | Year |
|---|---|
Novel approach to decrease platelet exposure in a pediatric Jehovah Witness patient.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Child; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Jehovah's Witnesses; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Platelet Transfusion; Prednisone; Receptors, Fc; Recombinant Fusion Proteins; Remission Induction; Rituximab; Thrombocytopenia; Thrombopoietin; Treatment Refusal; Vincristine | 2019 |
Acute myelogenous leukemia in an adult with thrombocytopenia with absent radii syndrome.
Topics: Abnormalities, Multiple; Adult; Antineoplastic Combined Chemotherapy Protocols; Cell Differentiation; Cytarabine; Cytokines; Female; Genetic Predisposition to Disease; Humans; Idarubicin; Leukemia, Myeloid, Acute; Menorrhagia; Neoplasm Proteins; Platelet Count; Proto-Oncogene Proteins; Radius; Receptors, Cytokine; Receptors, Thrombopoietin; Recurrence; Remission Induction; Risk; Syndrome; Thrombocytopenia | 2003 |
Hemolytic uremic syndrome after high dose chemotherapy with autologous stem cell support.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Carmustine; Cyclophosphamide; Cytarabine; Etoposide; Fatal Outcome; Female; Hematopoietic Stem Cell Transplantation; Hemolytic-Uremic Syndrome; Humans; Hypertension; Immunoglobulins, Intravenous; Male; Middle Aged; Plasma; Remission Induction; Renal Insufficiency; Retinal Vein Occlusion; Thiotepa; Thrombocytopenia; Transplantation, Autologous; Vincristine | 1995 |
High-dose cytarabine and mitoxantrone as salvage therapy for refractory non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cytarabine; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Leukopenia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Neutropenia; Remission Induction; Salvage Therapy; Thrombocytopenia | 1997 |
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infections; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Survival Analysis; Thrombocytopenia; Vincristine | 2001 |
Management of acute leukemia in adults.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Blood Transfusion; Cytarabine; Daunorubicin; Drug Therapy, Combination; Hematopoietic Stem Cells; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Middle Aged; Prognosis; Remission, Spontaneous; Thioguanine; Thrombocytopenia; Time Factors | 1975 |
The intracavitary administration of cytarabine to patients with nonhematopoietic malignancies: pharmacologic rationale and results of clinical trials.
Topics: Abdomen; Antineoplastic Combined Chemotherapy Protocols; Cell Line; Cisplatin; Cytarabine; Dose-Response Relationship, Drug; Doxorubicin; Drug Evaluation; Female; Humans; Kidney Diseases; Kinetics; Leukopenia; Nausea; Neoplasms; Ovarian Neoplasms; Pain; Peritoneal Cavity; Peritonitis; Pleura; Thrombocytopenia; Vomiting | 1985 |
Drug-induced thrombocytopenia.
Topics: Aged; Agglutination Tests; Alkaloids; Alkylating Agents; Anti-Bacterial Agents; Anticonvulsants; Antigen-Antibody Reactions; Azathioprine; Blood Cell Count; Blood Platelet Disorders; Blood Platelets; Bone Marrow; Bone Marrow Examination; Clot Retraction; Complement Fixation Tests; Cytarabine; Drug-Related Side Effects and Adverse Reactions; Fluorouracil; Humans; Hypoglycemic Agents; Infant, Newborn; Kidney Function Tests; Liver Function Tests; Male; Mercaptopurine; Middle Aged; Prothrombin Time; Thrombocytopenia; Tranquilizing Agents; Vinblastine; Vincristine | 1972 |
[New principles of treatment in acute leukemia].
Topics: Adolescent; Adult; Antineoplastic Agents; Central Nervous System Diseases; Child; Cyclophosphamide; Cytarabine; Female; Guanidines; Humans; Hydroxyurea; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Leukopenia; Male; Mercaptopurine; Methotrexate; Middle Aged; Nitroso Compounds; Prednisone; Thrombocytopenia; Urea; Uric Acid; Vincristine | 1970 |
48 trial(s) available for cytarabine and Thrombopenia
| Article | Year |
|---|---|
Ibrutinib-rituximab followed by R-HCVAD as frontline treatment for young patients (≤65 years) with mantle cell lymphoma (WINDOW-1): a single-arm, phase 2 trial.
Topics: Adenine; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Humans; Lymphoma, Mantle-Cell; Lymphopenia; Methotrexate; Middle Aged; Piperidines; Rituximab; Thrombocytopenia; Treatment Outcome; Vincristine | 2022 |
Phase I study of ADI-PEG20 plus low-dose cytarabine for the treatment of acute myeloid leukemia.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Arginine; Argininosuccinate Synthase; Cytarabine; Drug Administration Schedule; Female; Humans; Hydrolases; Injections, Intramuscular; Injections, Subcutaneous; Leukemia, Myeloid, Acute; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Polyethylene Glycols; Thrombocytopenia; Treatment Outcome | 2021 |
Combination of vorinostat and low dose cytarabine for patients with azacitidine-refractory/relapsed high risk myelodysplastic syndromes.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Cytarabine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Hydroxamic Acids; In Vitro Techniques; Middle Aged; Myelodysplastic Syndromes; Nausea; Neutropenia; Recurrence; Risk Factors; Survival Analysis; Thrombocytopenia; Treatment Outcome; Vomiting; Vorinostat | 2014 |
A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M/IVAC regimen for untreated Burkitt's lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Polyethylene Glycols; Rituximab; Thrombocytopenia; Treatment Outcome; Vincristine; Young Adult | 2013 |
A multicenter, phase II study of maintenance azacitidine in older patients with acute myeloid leukemia in complete remission after induction chemotherapy.
Topics: Aged; Aged, 80 and over; Anthracyclines; Antimetabolites, Antineoplastic; Azacitidine; Cytarabine; Female; Humans; Induction Chemotherapy; Injections, Subcutaneous; Leukemia, Myeloid, Acute; Male; Middle Aged; Neutropenia; Pilot Projects; Remission Induction; Survival Analysis; Thrombocytopenia | 2015 |
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial.
Topics: Acute Kidney Injury; Anemia; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Comparative Effectiveness Research; Cytarabine; Death, Sudden; Denmark; Dexamethasone; Disease-Free Survival; Female; Follow-Up Studies; Gastrointestinal Diseases; Germany; Heart Injuries; Hematopoietic Stem Cell Transplantation; Humans; Hyperglycemia; Induction Chemotherapy; Infections; Intraocular Lymphoma; Italy; Kaplan-Meier Estimate; Lymphoma, B-Cell; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Mucositis; Neurotoxicity Syndromes; Neutropenia; Optic Nerve Neoplasms; Poisoning; Radiotherapy, Adjuvant; Remission Induction; Rituximab; Stroke; Switzerland; Thiotepa; Thrombocytopenia; Thrombosis; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; United Kingdom | 2016 |
Low dose interleukin-2 following intensification therapy with high dose cytarabine for acute myelogenous leukemia in first complete remission.
Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cytarabine; Dose-Response Relationship, Drug; Fatigue; Feasibility Studies; Female; Fever; Follow-Up Studies; Humans; Interleukin-2; Killer Cells, Natural; Leukemia, Myeloid; Male; Middle Aged; Recombinant Proteins; Remission Induction; Survival Analysis; T-Lymphocytes; Thrombocytopenia; Time Factors; Treatment Outcome | 2008 |
Alemtuzumab and DHAP (A-DHAP) is effective for relapsed peripheral T-cell lymphoma, unspecified: interim results of a phase II prospective study.
Topics: Adult; Alemtuzumab; Anemia; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Leukopenia; Longitudinal Studies; Lymphoma, T-Cell; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Prospective Studies; Recurrence; Salvage Therapy; Survival Analysis; T-Lymphocytes; Thrombocytopenia; Treatment Outcome; Young Adult | 2009 |
[Efficacy of modified B-NHL-BFM-90 protocol on anaplastic T-cell lymphoma in children and adolescents].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; L-Lactate Dehydrogenase; Leukopenia; Lymphoma, Large-Cell, Anaplastic; Male; Methotrexate; Neoplasm Staging; Remission Induction; Stem Cell Transplantation; Thrombocytopenia; Vincristine; Vindesine | 2009 |
Evaluation of the (R)VAD+C regimen for the treatment of newly diagnosed mantle cell lymphoma. Combined results of two prospective phase II trials from the French GOELAMS group.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Combined Modality Therapy; Cytarabine; Dexamethasone; Disease-Free Survival; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Ki-67 Antigen; Lymphoma, Mantle-Cell; Male; Middle Aged; Neutropenia; Prognosis; Prospective Studies; Rituximab; Stem Cell Transplantation; Thrombocytopenia; Transplantation, Autologous; Treatment Outcome; Vincristine; Young Adult | 2010 |
Treatment of therapy-related myeloid neoplasms with high-dose cytarabine/mitoxantrone followed by hematopoietic stem cell transplant.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Dose-Response Relationship, Drug; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mitoxantrone; Myeloid Cells; Neoplasms, Second Primary; Neutropenia; Survival Analysis; Thrombocytopenia; Treatment Outcome; Young Adult | 2010 |
Effect of genetic alterations of cytarabine- metabolizing enzymes in childhood acute lymphoblastic leukemia.
Topics: Adolescent; Alleles; Antigens, CD19; Antimetabolites, Antineoplastic; Child; Child, Preschool; Cytarabine; Cytidine Deaminase; Deoxycytidine Kinase; Dose-Response Relationship, Drug; Female; Flow Cytometry; Gene Frequency; Genotype; Humans; Infant; Leukocyte Common Antigens; Male; Mucositis; Neoplasm Staging; Neoplasm, Residual; Polymorphism, Single Nucleotide; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Thrombocytopenia; Treatment Outcome | 2010 |
Imatinib plus peginterferon alfa-2a in chronic myeloid leukemia.
Topics: Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cytarabine; Female; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Interferon alpha-2; Interferon-alpha; Leukemia, Myeloid, Chronic-Phase; Male; Middle Aged; Neutropenia; Piperazines; Polyethylene Glycols; Proto-Oncogene Proteins c-abl; Pyrimidines; Recombinant Proteins; Remission Induction; RNA, Neoplasm; Stem Cells; Survival Analysis; Thrombocytopenia; Transcription, Genetic; Treatment Outcome | 2010 |
Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia.
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Choice Behavior; Cytarabine; Decision Making; Decitabine; Drug Administration Schedule; Female; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Neutropenia; Palliative Care; Patient Participation; Remission Induction; Risk Assessment; Risk Factors; Thrombocytopenia; Treatment Outcome | 2012 |
Time-intensified dexamethasone/cisplatin/cytarabine: an effective salvage therapy with low toxicity in patients with relapsed and refractory Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Drug Administration Schedule; Female; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Infusions, Intravenous; Leukopenia; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Recurrence; Salvage Therapy; Thrombocytopenia; Treatment Outcome | 2002 |
Results of a prospective phase 2 study combining imatinib mesylate and cytarabine for the treatment of Philadelphia-positive patients with chronic myelogenous leukemia in chronic phase.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Biomarkers, Tumor; Cytarabine; Drug Administration Schedule; Female; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Male; Middle Aged; Neutropenia; Piperazines; Pyrimidines; Remission Induction; Safety; Thrombocytopenia | 2003 |
Idarubicin and standard-dose cytosine arabinoside in adults with recurrent and refractory acute lymphocytic leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Disease-Free Survival; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Idarubicin; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survival Rate; Thrombocytopenia | 2004 |
Ex vivo expansion of megakaryocyte precursor cells in autologous stem cell transplantation for relapsed malignant lymphoma.
Topics: Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cell Culture Techniques; Cells, Cultured; Cyclophosphamide; Cytarabine; Erythroid Precursor Cells; Humans; Integrin beta3; Lymphoma; Megakaryocytes; Melphalan; Peripheral Blood Stem Cell Transplantation; Platelet Membrane Glycoprotein IIb; Platelet Transfusion; Salvage Therapy; Thrombocytopenia; Thrombopoietin; Transplantation, Autologous; Treatment Outcome | 2004 |
[Clinical randomized comparative trial of ProMACE-CytaBOM regimen and CHOP regimen in treating non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Leukopenia; Lymphoma, B-Cell; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Nausea; Prednisone; Remission Induction; Survival Rate; Thrombocytopenia; Vincristine | 2005 |
Aclarubicin and low-dose Cytosine arabinoside in combination with granulocyte colony-stimulating factor in treating acute myeloid leukemia patients with relapsed or refractory disease and myelodysplastic syndrome: a multicenter study of 112 Chinese patien
Topics: Aclarubicin; Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Dose-Response Relationship, Drug; Female; Granulocyte Colony-Stimulating Factor; Humans; Injections, Subcutaneous; Leukemia, Myeloid; Male; Middle Aged; Myelodysplastic Syndromes; Neutropenia; Survival Analysis; Thrombocytopenia; Treatment Outcome | 2005 |
Rituximab plus ASHAP for the treatment of patients with relapsed or refractory aggressive non-Hodgkin's lymphoma: a single-centre study of 20 patients.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Methylprednisolone Hemisuccinate; Middle Aged; Nausea; Neoplasm Recurrence, Local; Neutropenia; Prognosis; Retrospective Studies; Rituximab; Salvage Therapy; Thrombocytopenia; Treatment Outcome | 2007 |
Efficacy and safety of rituximab combined with ESHAP chemotherapy for the treatment of relapsed/refractory aggressive B-cell non-Hodgkin lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Creatinine; Cytarabine; Etoposide; Female; Humans; Lymphoma, B-Cell; Male; Methylprednisolone; Middle Aged; Nausea; Neoplasm Recurrence, Local; Neutropenia; Platelet Count; Prospective Studies; Rituximab; Thrombocytopenia; Treatment Outcome | 2007 |
[Efficacy of thalidomide combined dexamethasone on newly diagnosed multiple myeloma].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Constipation; Cytarabine; Dexamethasone; Disease-Free Survival; Fatigue; Follow-Up Studies; Humans; Leukopenia; Middle Aged; Multiple Myeloma; Remission Induction; Survival Rate; Thalidomide; Thrombocytopenia; Vincristine | 2007 |
Intensive cytosine arabinoside therapy in small cell carcinoma of the lung.
Topics: Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Infusions, Parenteral; Lung Neoplasms; Male; Middle Aged; Nausea; Thrombocytopenia; Vincristine; Vomiting | 1984 |
Acute myelogenous leukaemia: maintenance chemotherapy after early consolidation treatment does not prolong survival.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child; Clinical Trials as Topic; Cytarabine; Evaluation Studies as Topic; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Prednisone; Prognosis; Random Allocation; Thioguanine; Thrombocytopenia; Vincristine | 1984 |
Randomized trial of cyclophosphamide, doxorubicin, and 5-fluorouracil alone or alternating with a "cycle active" non-cross-resistant combination in women with visceral metastatic breast cancer: a Southeastern Cancer Study Group project.
Topics: Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Drug Resistance; Female; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Methotrexate; Nausea; Random Allocation; Thrombocytopenia; Vincristine; Vomiting | 1984 |
Failure of lithium to limit neutropenia significantly during induction therapy of acute myelogenous leukemia. A Southeastern Cancer Study Group study.
Topics: Age Factors; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Evaluation; Female; Fever; Humans; Infections; Leukemia, Myeloid, Acute; Lithium; Lithium Carbonate; Male; Middle Aged; Neutropenia; Random Allocation; Thrombocytopenia | 1984 |
Prolonged daily administration of oral etoposide in lymphoma following prior therapy with adriamycin, an ifosfamide-containing salvage combination, and intravenous etoposide.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Infusions, Intravenous; Leukopenia; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Palliative Care; Remission Induction; Salvage Therapy; Survival Rate; Thrombocytopenia | 1995 |
Phase I study of a continuous infusion of high-dose ara-C in conjunction with a fixed dose of 2'-deoxycytidine (IND 28108) in patients with refractory leukemia: an interim report.
Topics: Adult; Aged; Blast Crisis; Cytarabine; Deoxycytidine; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Neutropenia; Remission Induction; Thrombocytopenia | 1993 |
Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neutropenia; Prednisone; Survival Analysis; Thrombocytopenia; Vincristine | 1996 |
Idarubicin and intermediate dose ARA-C followed by consolidation chemotherapy or bone marrow transplantation in relapsed or refractory acute myeloid leukemia.
Topics: Acute Disease; Adult; Agranulocytosis; Antibiotics, Antineoplastic; Bone Marrow Transplantation; Cytarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Humans; Idarubicin; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Male; Nausea; Remission Induction; Thrombocytopenia; Treatment Outcome; Vomiting | 1997 |
High-dose cytarabine and mitoxantrone as salvage therapy for refractory non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cytarabine; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Leukopenia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Neutropenia; Remission Induction; Salvage Therapy; Thrombocytopenia | 1997 |
Mitoxantrone-DHAP with GM-CSF: an active but myelosuppressive salvage therapy for relapsed/refractory aggressive non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Disease-Free Survival; Drug Administration Schedule; Female; Gastrointestinal Diseases; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Life Tables; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Neutropenia; Remission Induction; Salvage Therapy; Sepsis; Survival Analysis; Thrombocytopenia; Treatment Outcome | 1999 |
Results of topotecan-based combination therapy in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Humans; Karyotyping; Leukemia, Myelomonocytic, Chronic; Male; Middle Aged; Myelodysplastic Syndromes; Neutropenia; Platelet Count; Remission Induction; Risk Assessment; Survival Rate; Thrombocytopenia; Topotecan | 1999 |
Use of recombinant human granulocyte colony-stimulating factor to increase chemotherapy dose-intensity: a randomized trial in very high-risk childhood acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Dexamethasone; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Infant; Infant, Newborn; Male; Methotrexate; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recombinant Proteins; Thrombocytopenia; Treatment Outcome; Vincristine | 2000 |
A phase-II trial of all trans retinoic acid and low-dose cytosine arabinoside for the treatment of high-risk myelodysplastic syndromes.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anemia; Cytarabine; Dose-Response Relationship, Drug; Female; Humans; Hypertriglyceridemia; Infections; Male; Middle Aged; Myelodysplastic Syndromes; Neutropenia; Thrombocytopenia; Tretinoin | 2000 |
Cisplatin, cytarabine, caffeine, and continuously infused 5-fluorouracil (PACE) in the treatment of advanced pancreatic carcinoma: a phase II study.
Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; CA-19-9 Antigen; Caffeine; Cisplatin; Confidence Intervals; Cytarabine; Female; Fluorouracil; Humans; Male; Middle Aged; Neutropenia; Pancreatic Neoplasms; Phosphodiesterase Inhibitors; Remission Induction; Survival Rate; Thrombocytopenia | 2000 |
Value of autologous stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS phase II study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow Purging; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Female; Genes, bcl-2; Genes, Immunoglobulin; Hematopoietic Stem Cell Transplantation; Humans; Lung Diseases, Interstitial; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm, Residual; Neutropenia; Polymerase Chain Reaction; Prednisone; Recurrence; Remission Induction; Sepsis; Survival Analysis; Thrombocytopenia; Translocation, Genetic; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vincristine | 2000 |
Daunorubicin continuous infusion induces more toxicity than bolus infusion in acute lymphoblastic leukemia induction regimen: a randomized study.
Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Etoposide; Female; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Infusions, Intravenous; Injections, Intravenous; Life Tables; Male; Methotrexate; Middle Aged; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Survival Analysis; Thrombocytopenia; Treatment Outcome; Vincristine | 2001 |
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infections; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Survival Analysis; Thrombocytopenia; Vincristine | 2001 |
Cisplatin, fludarabine, and cytarabine: a novel, pharmacologically designed salvage therapy for patients with refractory, histologically aggressive or mantle cell non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Disease-Free Survival; Female; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intravenous; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Prognosis; Recurrence; Salvage Therapy; Thrombocytopenia; Treatment Outcome; Vidarabine | 2002 |
Granulocyte-macrophage colony-stimulating factor (GM-CSF) priming with successive concomitant low-dose Ara-C for elderly patients with secondary/refractory acute myeloid leukemia or advanced myelodysplastic syndrome.
Topics: Acute Disease; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukemia, Myeloid; Male; Middle Aged; Neutropenia; Survival Rate; Thrombocytopenia; Treatment Outcome | 2002 |
Low-dose ara-C therapy for acute myelogenous leukemia in elderly patients.
Topics: Aged; Aging; Clinical Trials as Topic; Cytarabine; Drug Administration Schedule; Female; Granulocytes; Hemorrhage; Humans; Infections; Injections, Subcutaneous; Leukemia, Myeloid, Acute; Leukopenia; Male; Middle Aged; Prospective Studies; Remission Induction; Thrombocytopenia | 1989 |
A multicentre study on intensive induction and consolidation therapy in acute myelogenous leukaemia.
Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cytarabine; Daunorubicin; Etoposide; Humans; Infections; Leukemia, Myeloid, Acute; Middle Aged; Neutropenia; Remission Induction; Thrombocytopenia | 1988 |
High-dose cytosine arabinoside in the treatment of preleukemic disorders: a leukemia intergroup study.
Topics: Adult; Aged; Clinical Trials as Topic; Cytarabine; Drug Administration Schedule; Humans; Middle Aged; Myelodysplastic Syndromes; Myeloproliferative Disorders; Platelet Count; Preleukemia; Thrombocytopenia | 1986 |
Treatment of acute myeloid leukaemia with daunorubicin, cytosine arabinoside, mercaptopurine, L-asparaginase, prednisone and thioguanine: results of treatment with five multiple-drug schedules. Report of the Medical Research Council's Working Party on Leu
Topics: Adolescent; Adult; Age Factors; Aged; Asparaginase; Blood Platelets; Child; Clinical Trials as Topic; Cytarabine; Daunorubicin; Drug Therapy, Combination; Female; Humans; Leukemia, Myeloid, Acute; Leukocyte Count; Lymphocytes; Male; Mercaptopurine; Middle Aged; Prednisone; Prognosis; Remission, Spontaneous; Thioguanine; Thrombocytopenia | 1974 |
Comparison of treatment of metastatic gastrointestinal cancer with 5-fluorouracil (5-FU) to a combination of 5-FU with cytosine arabinoside.
Topics: Adenocarcinoma; Clinical Trials as Topic; Colonic Neoplasms; Cytarabine; Diabetic Ketoacidosis; Diarrhea; Drug Combinations; Evaluation Studies as Topic; Fluorouracil; Gastrointestinal Neoplasms; Humans; Leukopenia; Placebos; Stomach Neoplasms; Thrombocytopenia; Vomiting | 1972 |
BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea; NSC-409962) in the treatment of malignant brain tumor--a preliminary report.
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Alopecia; Antineoplastic Agents; Aspartate Aminotransferases; Blood-Brain Barrier; Brain Neoplasms; Carcinoma, Bronchogenic; Child; Child, Preschool; Clinical Trials as Topic; Cystitis; Cytarabine; Evaluation Studies as Topic; Female; Glioma; Humans; Leukopenia; Male; Medulloblastoma; Middle Aged; Nitroso Compounds; Nitrosourea Compounds; Thrombocytopenia; Urea | 1970 |
92 other study(ies) available for cytarabine and Thrombopenia
| Article | Year |
|---|---|
A case of acute megakaryoblastic leukaemia (FAB M7), a rare type of acute myeloid leukemia (AML), in a teenager.
Topics: Anemia; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Blood Transfusion; Cytarabine; Daunorubicin; Fatigue; Female; Humans; Immunophenotyping; Leukemia, Megakaryoblastic, Acute; Lost to Follow-Up; Muscle Weakness; Thrombocytopenia; Young Adult | 2018 |
Linezolid is safe on platelet count for AML patients during myelosuppression after consolidation chemotherapy.
Topics: Adult; Anti-Bacterial Agents; Bone Marrow; Consolidation Chemotherapy; Cytarabine; Female; Humans; Idarubicin; Leukemia, Myeloid, Acute; Linezolid; Male; Middle Aged; Platelet Count; Retrospective Studies; Thrombocytopenia | 2020 |
TPO-mimetics for chemotherapy-induced thrombocytopenia: timing matters.
Topics: Cytarabine; Humans; Prospective Studies; Receptors, Fc; Thrombocytopenia; Thrombopoietin | 2018 |
A review of R-DHAP administration in the outpatient setting and a case of the alternative regimen R-DHAX given outpatient for refractory diffuse large B-cell lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Neoplasm Recurrence, Local; Outpatients; Oxaliplatin; Rituximab; Salvage Therapy; Thrombocytopenia | 2019 |
Evaluation of a multi-agent chemotherapy protocol combining dexamethasone, melphalan, actinomycin D, and cytarabine for the treatment of resistant canine non-Hodgkin high-grade lymphomas: a single centre's experience.
Topics: Animals; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cytarabine; Dactinomycin; Databases, Factual; Dexamethasone; Dog Diseases; Dogs; Female; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Melphalan; Neoplasm Recurrence, Local; Neutropenia; Remission Induction; Schools, Veterinary; Thrombocytopenia; Treatment Outcome; United Kingdom | 2019 |
Blue toes and a new pair of shoes--challenges in diagnosis and treatment of acute myelogenous leukemia.
Topics: Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Aorta, Abdominal; Arterial Occlusive Diseases; Bone Marrow Examination; Combined Modality Therapy; Cyanosis; Cytarabine; Diagnosis, Differential; Disseminated Intravascular Coagulation; Fatal Outcome; Female; Humans; Idarubicin; Ischemia; Leukemia, Myeloid, Acute; Magnetic Resonance Imaging; Middle Aged; Purpura, Thrombotic Thrombocytopenic; Shoes; Thrombectomy; Thrombocytopenia; Thrombosis; Toes; Ultrasonography | 2013 |
Fractionated gemtuzumab ozogamicin and standard dose cytarabine produced prolonged second remissions in patients over the age of 55 years with acute myeloid leukemia in late first relapse.
Topics: Aged; Aminoglycosides; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Compassionate Use Trials; Consolidation Chemotherapy; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Filgrastim; Gemtuzumab; Granulocyte Colony-Stimulating Factor; Humans; Immunophenotyping; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Male; Methylprednisolone; Middle Aged; Neutropenia; Nucleophosmin; Recombinant Proteins; Remission Induction; Salvage Therapy; Thrombocytopenia | 2014 |
Clinical outcomes of patients with newly diagnosed primary central nervous system lymphoma are comparable on treatment with high-dose methotrexate plus temozolomide and with high-dose methotrexate plus cytarabine: a single-institution experience.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Dacarbazine; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Neutropenia; Remission Induction; Temozolomide; Thrombocytopenia; Treatment Outcome; Young Adult | 2014 |
[Cohort Study on GHA and New Combined Priming Chemotherapeutic Regimens in Treatment of Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome].
Topics: Aclarubicin; Antineoplastic Combined Chemotherapy Protocols; B7-1 Antigen; Cohort Studies; Cytarabine; Doxorubicin; Granulocyte Colony-Stimulating Factor; Granulocytes; Harringtonines; Homoharringtonine; Humans; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Recurrence; Thrombocytopenia | 2015 |
[Effect of Bear Bile Powder and Its Succedaneum on Peripheral Blood and Bone Marrow Megakaryocytes in Mouse Model with Thrombocytopenia Induced by Cytosine Arabinoside].
Topics: Animals; Bile; Bone Marrow; Bone Marrow Cells; Cytarabine; Disease Models, Animal; Megakaryocytes; Mice; Spleen; Thrombocytopenia | 2015 |
Efficacy and toxicity of carboplatin and cytarabine chemotherapy for dogs with relapsed or refractory lymphoma (2000-2013).
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cytarabine; Dog Diseases; Dogs; Female; Lymphoma; Male; Neutropenia; Recurrence; Retrospective Studies; Thrombocytopenia; Treatment Failure | 2017 |
[Effectiveness of CLAT Protocol for Treating Patients with Refractory Acute Myeloid Leukemia].
Topics: Adolescent; Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cytarabine; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Remission Induction; Thrombocytopenia; Topotecan; Young Adult | 2016 |
[Efficacy Comparison of Low dose Thalidomide Combined with Modified VCMP and VAD regimens for Treatment of Aged MM Patients].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Humans; Melphalan; Multiple Myeloma; Prednisone; Remission Induction; Survival Rate; Thalidomide; Thrombocytopenia; Vincristine | 2016 |
Rituximab-induced acute thrombocytopenia: a case report and review of the literature.
Topics: Acute Disease; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Examination; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Humans; Immunophenotyping; Infusions, Parenteral; L-Lactate Dehydrogenase; Lymphoma, Mantle-Cell; Male; Methotrexate; Middle Aged; Platelet Count; Rituximab; Splenomegaly; Thrombocytopenia; Vincristine | 2009 |
Influence of methylene tetrahydrofolate reductase polymorphisms and coadministration of antimetabolites on toxicity after high dose methotrexate.
Topics: Antimetabolites, Antineoplastic; Child; Child, Preschool; Cytarabine; Female; Humans; Male; Mercaptopurine; Methotrexate; Methylenetetrahydrofolate Reductase (NADPH2); Neutropenia; Polymorphism, Genetic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Thrombocytopenia | 2008 |
Successful treatment of severe gastrointestinal bleeding after chemotherapy in acute myeloblastic leukemia with recombinant activated factor VII : report on one case and review of other uses in acute leukemias.
Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Factor VIIa; Female; Gastrointestinal Hemorrhage; Humans; Idarubicin; Injections, Intravenous; Leukemia, Myeloid, Acute; Recombinant Proteins; Remission Induction; Thrombocytopenia; Treatment Outcome | 2010 |
Front-line treatment of mantle cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Combined Modality Therapy; Cytarabine; Dexamethasone; Disease-Free Survival; Humans; Ki-67 Antigen; Lymphoma, Mantle-Cell; Neutropenia; Prognosis; Stem Cell Transplantation; Thrombocytopenia; Transplantation, Autologous; Treatment Outcome; Vincristine | 2010 |
Equivalence of pegfilgrastim and filgrastim in lymphoma patients treated with BEAM followed by autologous stem cell transplantation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Drug Administration Schedule; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Length of Stay; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Neutropenia; Peripheral Blood Stem Cell Transplantation; Podophyllotoxin; Polyethylene Glycols; Recombinant Proteins; Severity of Illness Index; Thrombocytopenia; Time Factors; Transplantation, Autologous; Treatment Outcome; Young Adult | 2010 |
[Percutaneous coronary intervention in a patient with acute myeloid leukemia].
Topics: Angioplasty, Balloon, Coronary; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow; Coronary Angiography; Cytarabine; Female; Heart Failure; Humans; Leukemia, Myeloid, Acute; Lymph Nodes; Middle Aged; Mitoxantrone; Mitral Valve Insufficiency; Myocardial Infarction; Myocardial Ischemia; Platelet Aggregation Inhibitors; Platelet Transfusion; Remission Induction; Stents; Thrombocytopenia | 2012 |
Salvage treatment with etoposide (VP-16), ifosfamide and cytarabine (Ara-C) for patients with recurrent primary central nervous system lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Child, Preschool; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Life Tables; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Analysis; Thrombocytopenia; Vincristine | 2003 |
Intestinal toxicity during induction chemotherapy with cytarabine-based regimens in adult acute myeloid leukemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Evaluation; Drug-Related Side Effects and Adverse Reactions; Enterocolitis, Necrotizing; Female; Humans; Infusions, Parenteral; Injections, Subcutaneous; Intestinal Diseases; Leukemia, Myeloid; Male; Middle Aged; Neutropenia; Remission Induction; Retrospective Studies; Thrombocytopenia | 2003 |
Treatment of lymphoma relapses after allogeneic hematopoietic stem cell transplantation with intensive chemotherapy followed by infusion of hematopoietic stem cell from the original donor.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Female; Graft vs Host Disease; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Melphalan; Middle Aged; Neutropenia; Recurrence; Remission Induction; Thrombocytopenia; Tomography, X-Ray Computed; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2003 |
[Successful treatment of acute myelomonocytic leukemia developed from essential thrombocythemia with cytarabine plus etoposide].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Humans; Leukemia, Myelomonocytic, Acute; Male; Thrombocytopenia; Treatment Outcome | 2004 |
Veno-occlusive disease of the liver associated with chronic myelomonocytic leukemia treated with vincristine and standard doses of cytarabine.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Disease Progression; Fatal Outcome; Hepatic Veno-Occlusive Disease; Humans; Hypoalbuminemia; Leukemia, Myelomonocytic, Chronic; Male; Paresis; Renal Insufficiency; Thrombocytopenia; Vincristine | 2005 |
Chemotherapy-induced thrombocytopenia derives from the selective death of megakaryocyte progenitors and can be rescued by stem cell factor.
Topics: Adult; Antineoplastic Agents; Apoptosis; Cisplatin; Cytarabine; Enzyme Activation; Erythroid Precursor Cells; Humans; Megakaryocytes; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-kit; Stem Cell Factor; Thrombocytopenia; Vincristine | 2007 |
Clinical trial of low-dose Ara-C in the treatment of acute leukemia and myelodysplasia.
Topics: Anemia, Aplastic; Blood Cell Count; Cell Differentiation; Cytarabine; Dose-Response Relationship, Drug; Female; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Middle Aged; Primary Myelofibrosis; Thrombocytopenia | 1984 |
Aclarubicin in the treatment of acute nonlymphocytic leukemia refractory to treatment with daunorubicin and cytarabine: a phase II trial.
Topics: Aclarubicin; Acute Disease; Adult; Aged; Antibiotics, Antineoplastic; Cytarabine; Daunorubicin; Drug Evaluation; Heart; Humans; Leukemia; Leukopenia; Middle Aged; Naphthacenes; Prospective Studies; Thrombocytopenia | 1984 |
The treatment of histiocytic lymphoma.
Topics: Antineoplastic Agents; Cyclophosphamide; Cytarabine; Doxorubicin; Humans; Leucovorin; Leukopenia; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Prednisone; Procarbazine; Radiotherapy, High-Energy; Thrombocytopenia; Vincristine | 1980 |
Lithium and granulocytopenia during induction therapy of acute myelogenous leukemia: update of an ongoing trial.
Topics: Agranulocytosis; Bacterial Infections; Cytarabine; Daunorubicin; Fever; Humans; Leukemia, Myeloid, Acute; Lithium; Middle Aged; Neutropenia; Thrombocytopenia; Time Factors | 1980 |
Acute myelogenous leukemia: successful treatment of relapse with cytosine arabinoside, VP 16-213, vincristine and vinblastine (A-triple-V).
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Therapy, Combination; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Recurrence; Thrombocytopenia; Vinblastine; Vincristine | 1982 |
Salvage chemotherapy for non-Hodgkin's lymphoma.
Topics: Adult; Aged; Cytarabine; Drug Therapy, Combination; Female; Humans; Leukopenia; Lomustine; Lymphoma; Male; Middle Aged; Nitrosourea Compounds; Prednisone; Thrombocytopenia | 1982 |
Intensified remission induction therapy for acute nonlymphocytic leukemia (ANLL). Treatment report on 60 patients.
Topics: Acute Disease; Adolescent; Adult; Aged; Cytarabine; Daunorubicin; Humans; Leukemia; Middle Aged; Thioguanine; Thrombocytopenia | 1981 |
Factor VIII inhibitor prior to and during secondary acute nonlymphocytic leukemia in a patient with cured Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Blood Transfusion; Combined Modality Therapy; Cytarabine; Factor VIII; Female; Granulocyte Colony-Stimulating Factor; Hemophilia A; Hemorrhage; Hodgkin Disease; Humans; Immunologic Factors; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Lymphatic Irradiation; Mechlorethamine; Middle Aged; Neoplasms, Second Primary; Plasmapheresis; Prednisone; Procarbazine; Prothrombin; Remission Induction; Thrombocytopenia; Vidarabine; Vincristine | 1995 |
E-SHAP: an effective treatment in selected patients with relapsed non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Neutropenia; Recurrence; Remission Induction; Salvage Therapy; Survival Rate; Thrombocytopenia | 1994 |
Post-remission cytopenias following intense induction chemotherapy for acute myeloid leukemia.
Topics: Acute Disease; Adolescent; Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Daunorubicin; Humans; Leukemia, Myeloid; Middle Aged; Mitoxantrone; Neutropenia; Recurrence; Remission Induction; Thrombocytopenia; Time Factors; Treatment Outcome | 1994 |
Combination chemotherapy of carboplatin and cytosine arabinoside for high-risk leukemia: a pilot study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cytarabine; Female; Humans; Leukemia; Male; Middle Aged; Neutropenia; Pilot Projects; Remission Induction; Risk Factors; Thrombocytopenia | 1995 |
Single weekly cytosine arabinoside and oral 6-thioguanine in patients with myelodysplastic syndrome and acute myeloid leukemia.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Aged, 80 and over; Cytarabine; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Injections, Subcutaneous; Leukemia, Myeloid; Male; Middle Aged; Myelodysplastic Syndromes; Palliative Care; Platelet Transfusion; Thioguanine; Thrombocytopenia | 1997 |
Prophylactic platelet transfusion threshold during therapy for adult acute myeloid leukemia: 10,000/microL versus 20,000/microL.
Topics: Acute Disease; Adolescent; Adult; Aged; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Etoposide; Hemorrhage; Humans; Idarubicin; Leukemia, Myeloid; Middle Aged; Mitoxantrone; Pancytopenia; Platelet Count; Platelet Transfusion; Retrospective Studies; Spain; Thrombocytopenia | 1998 |
Leukostasis followed by hemorrhage complicating the initiation of chemotherapy in patients with acute myeloid leukemia and hyperleukocytosis: a clinicopathologic report of four cases.
Topics: Acute Disease; Adult; Antimetabolites, Antineoplastic; Blood Coagulation Disorders; Cytarabine; Female; Hemorrhage; Humans; Leukemia, Myeloid; Leukocytosis; Leukostasis; Male; Middle Aged; Radiography; Thrombocytopenia | 1999 |
Complications of systemic chemotherapy as treatment of retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cyclosporine; Cytarabine; Etoposide; Female; Fever; Humans; Infant; Male; Methotrexate; Neutropenia; Organophosphorus Compounds; Retinal Neoplasms; Retinoblastoma; Thrombocytopenia; Vincristine | 2000 |
Treatment of patients with recurrent and primary refractory acute myelogenous leukemia using mitoxantrone and intermediate-dose cytarabine: a pharmacologically based regimen.
Topics: Adult; Age Factors; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Cerebellar Diseases; Cytarabine; Death, Sudden, Cardiac; Disease-Free Survival; Drug Eruptions; Exanthema; Female; Humans; Injections, Intravenous; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Neutropenia; Remission Induction; Thrombocytopenia; Treatment Outcome | 2000 |
Pituitary apoplexy in a patient with acute myeloid leukemia and thrombocytopenia.
Topics: Adenoma; Aged; Antimetabolites, Antineoplastic; Cytarabine; Female; Humans; Leukemia, Monocytic, Acute; Magnetic Resonance Imaging; Pituitary Apoplexy; Pituitary Gland; Pituitary Neoplasms; Radiography; Thrombocytopenia | 2000 |
Acute myelogenous leukemia as a late complication of the multimodality therapy for Hodgkin's disease.
Topics: Adult; Biopsy; Bone Marrow; Cytarabine; Daunorubicin; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Leukemia, Radiation-Induced; Male; Mechlorethamine; Prednisone; Procarbazine; Radiotherapy; Thrombocytopenia; Vinblastine; Vincristine | 1977 |
Tn polyagglutination preceding acute leukemia.
Topics: Aged; Cytarabine; Daunorubicin; Hemagglutination; Humans; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Male; Splenectomy; Thioguanine; Thrombocytopenia | 1979 |
Clinical studies of beta-thioguanine deoxyriboside alone and in combination with arabinosyl cytosine.
Topics: Acute Disease; Adolescent; Adult; Aged; Child; Child, Preschool; Cytarabine; Deoxyguanosine; Deoxyribonucleosides; Drug Therapy, Combination; Female; Guanosine; Humans; Leukemia; Leukopenia; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Remission, Spontaneous; Thioguanine; Thionucleosides; Thrombocytopenia; Time Factors | 1976 |
5-fluorouracil with cytosine arabinoside in metastatic gastrointestinal cancer.
Topics: Adult; Aged; Cytarabine; Drug Therapy, Combination; Fluorouracil; Gastrointestinal Neoplasms; Humans; Leukopenia; Neoplasm Metastasis; Thrombocytopenia | 1975 |
Leukemic reticuloendotheliosis: report of a case with prolonged remission following intensive chemotherapy.
Topics: Adult; Anemia, Aplastic; Cyclophosphamide; Cytarabine; Female; Humans; Leukemia; Leukopenia; Lymphatic Diseases; Remission, Spontaneous; Splenomegaly; Thrombocytopenia | 1976 |
Gingival status during chemical plaque control with or without prior mechanical plaque removal in patients with acute myeloid leukaemia.
Topics: Aclarubicin; Acute Disease; Adolescent; Aged; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Chlorhexidine; Cytarabine; Dental Calculus; Dental Plaque; Dental Scaling; Female; Gingival Hemorrhage; Gingivitis; Humans; Leukemia, Myeloid; Leukopenia; Male; Middle Aged; Mouthwashes; Netilmicin; Piperacillin; Premedication; Thrombocytopenia | 1992 |
High-dose cytosine arabinoside intensification for acute nonlymphocytic leukemia in patients over 56 years of age.
Topics: Aged; Aged, 80 and over; Cytarabine; Dose-Response Relationship, Drug; Drug Tolerance; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Remission Induction; Thrombocytopenia | 1992 |
Leukemia following cisplatin-based chemotherapy for ovarian carcinoma at Roswell Park.
Topics: Adult; Carcinoma, Papillary; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Middle Aged; Neoplasms, Second Primary; Ovarian Neoplasms; Thrombocytopenia | 1992 |
Neoadjuvant chemotherapy with cytosine arabinoside by continuous infusion and cisplatin for resectable squamous cell carcinoma of the esophagus.
Topics: Aged; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Cytarabine; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Pilot Projects; Thrombocytopenia | 1992 |
Cisplatin preceded by concurrent cytarabine and hydroxyurea: a pilot study based on an in vitro model.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; DNA Repair; Drug Administration Schedule; Drug Evaluation; Female; Humans; Hydroxyurea; Male; Middle Aged; Neoplasms; Thrombocytopenia | 1990 |
Extremely prolonged continuous intraperitoneal infusion of cytosine arabinoside.
Topics: Adult; Aged; Arabinofuranosyluracil; Ascitic Fluid; Colonic Neoplasms; Cytarabine; Female; Humans; Infusion Pumps, Implantable; Infusions, Parenteral; Leukopenia; Metabolic Clearance Rate; Middle Aged; Ovarian Neoplasms; Peritonitis; Thrombocytopenia; Time Factors | 1990 |
Effect of antifungal therapy on hematological recovery after intensive antileukemic chemotherapy.
Topics: Agranulocytosis; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Depression, Chemical; Hematopoiesis; Humans; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Life Tables; Mitoxantrone; Mycoses; Thioguanine; Thrombocytopenia | 1990 |
[4'-(9-acridinylamino)-methanesulfon-m-aniside (AMSA) combination salvage therapy in refractory acute non-lymphocytic leukemia in adults].
Topics: Adolescent; Adult; Aged; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Evaluation; Drug Resistance; Female; Humans; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Leukopenia; Male; Middle Aged; Prednisolone; Remission Induction; Thioguanine; Thrombocytopenia | 1989 |
Mitoxantrone and high-dose cytarabine as salvage therapy for refractory non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Evaluation; Humans; Infections; Lymphoma, Non-Hodgkin; Middle Aged; Mitoxantrone; Neutropenia; Remission Induction; Thrombocytopenia | 1989 |
Low-dose cytosine arabinoside in acute non-lymphoblastic leukemia.
Topics: Adolescent; Adult; Cytarabine; Drug Evaluation; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Thrombocytopenia | 1989 |
Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosi
Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Female; Humans; Leucovorin; Lymphoma; Male; Methotrexate; Middle Aged; Neoplasm Staging; Neutropenia; Peripheral Nervous System Diseases; Prednisone; Prognosis; Thrombocytopenia; Vincristine | 1986 |
Treatment of refractory lymphoma with methotrexate, VM-26 (teniposide), procarbazine, and dexamethasone: Cancer and Leukemia Group B study 7902.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Drug Evaluation; Female; Humans; Leucovorin; Leukopenia; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neutropenia; Procarbazine; Teniposide; Thrombocytopenia; Vincristine | 1988 |
Thrombotic thrombocytopenic purpura subsequent to acute myelogenous leukemia chemotherapy.
Topics: Antineoplastic Agents; Blood Transfusion; Cytarabine; Daunorubicin; Erythrocyte Transfusion; Female; Humans; Leukemia, Myeloid, Acute; Microcirculation; Mitomycins; Platelet Transfusion; Purpura; Thrombocytopenia | 1986 |
High-dose cytosine arabinoside: treatment and cellular pharmacology of chronic myelogenous leukemia blast crisis.
Topics: Adult; Brain Diseases; Cytarabine; Drug Evaluation; Female; Hemorrhage; Humans; Infections; Leukemia, Myeloid; Leukopenia; Male; Middle Aged; Thrombocytopenia; Time Factors | 1986 |
Treatment of acute leukaemia with m-AMSA in combination with cytosine arabinoside.
Topics: Aged; Amsacrine; Chemical and Drug Induced Liver Injury; Cytarabine; Female; Gastrointestinal Diseases; Heart Diseases; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Middle Aged; Neutropenia; Thrombocytopenia | 1986 |
Intensive consolidation chemotherapy for acute lymphoblastic leukaemia (UKALL X pilot study).
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Infant; Infections; Leukemia, Lymphoid; Male; Neutropenia; Pilot Projects; Thioguanine; Thrombocytopenia | 1987 |
Pharmacologic studies of low-dose and high-dose continuous infusion cytosine arabinoside.
Topics: Adult; Aged; Arabinofuranosylcytosine Triphosphate; Arabinofuranosyluracil; Cytarabine; DNA Replication; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Middle Aged; Replicon; Thrombocytopenia | 1987 |
13-cis-Retinoic acid does not increase the true remission rate and the duration of true remission (induced by cytotoxic chemotherapy) in patients with chronic phase chronic myelogenous leukemia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Chromosomes, Human, 21-22 and Y; Cytarabine; Daunorubicin; Humans; Isotretinoin; Leukemia, Myeloid; Leukopenia; Liver; Middle Aged; Stomatitis; Thioguanine; Thrombocytopenia; Time Factors; Tretinoin | 1985 |
Sequential high-dose cytosine arabinoside and L-asparaginase in childhood leukemia in relapse.
Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bacterial Infections; Child; Child, Preschool; Cytarabine; Female; Humans; Infant; Leukemia; Leukemia, Lymphoid; Male; Neutropenia; Recurrence; Thrombocytopenia | 1985 |
Low-dose cytosine arabinoside in the myelodysplastic syndromes and acute myelogenous leukemia.
Topics: Adult; Aged; Bone Marrow; Cytarabine; Female; Humans; Leukemia, Myeloid, Acute; Leukopenia; Male; Myeloproliferative Disorders; Thrombocytopenia | 1985 |
Continuous infusion of high-dose cytosine arabinoside for treatment of childhood acute leukemia and non-Hodgkin's lymphoma in relapse.
Topics: Acute Disease; Adolescent; Adult; B-Lymphocytes; Bacterial Infections; Burkitt Lymphoma; Cerebellar Ataxia; Child; Child, Preschool; Cytarabine; Female; Gastrointestinal Diseases; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Male; Neutropenia; Recurrence; Thrombocytopenia | 1985 |
High-dose adriamycin combination chemotherapy for intermediate and high-grade non-Hodgkin's lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Lymphoma; Male; Middle Aged; Neutropenia; Prednisone; T-Lymphocytes; Thrombocytopenia; Vincristine | 1985 |
[ABEP chemotherapy in the treatment of advanced non-Hodgkin's lymphomas].
Topics: Aclarubicin; Adult; Aged; Alopecia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Leukopenia; Lymphoma; Male; Middle Aged; Naphthacenes; Prednisolone; Thrombocytopenia; Vincristine | 1986 |
The use of high-dose cytosine arabinoside for non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Diseases; Cytarabine; Doxorubicin; Humans; Lymphoma; Middle Aged; Neutropenia; Prednisolone; Recurrence; Skin Diseases; Thrombocytopenia; Vincristine | 1985 |
Continuous infusion of high-dose 1-beta-D-arabinofuranosylcytosine: a phase I and pharmacological study.
Topics: Adult; Aged; Bone Marrow; Cytarabine; Drug Evaluation; Humans; Middle Aged; Neoplasms; Thrombocytopenia | 1985 |
Phase I trials of high-dose cytosine arabinoside (HDara-C) and HDara-C plus cisplatin in patients with advanced malignancies.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dose-Response Relationship, Drug; Drug Evaluation; Fatigue; Humans; Kidney Diseases; Leukopenia; Middle Aged; Neoplasms; Thrombocytopenia | 1985 |
Cytarabine-cis-platin interactions in patients with advanced cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asthenia; Carcinoma, Bronchogenic; Cisplatin; Cytarabine; Dose-Response Relationship, Drug; Drug Evaluation; Female; Gastrointestinal Diseases; Humans; Kidney Diseases; Leukopenia; Lung Neoplasms; Lymphoma; Male; Middle Aged; Neoplasms; Neutropenia; Thrombocytopenia | 1985 |
Combination chemotherapy: rationale for schedule selection and use of agents with independent toxicities in phase I and II clinical trials.
Topics: Acute Disease; Adult; Agranulocytosis; BCG Vaccine; Bleomycin; Cytarabine; Doxorubicin; Drug Combinations; Humans; Immunosuppression Therapy; Leukemia; Lymphopenia; Mitosis; Nitrogen Mustard Compounds; Prednisone; Thrombocytopenia; Vincristine | 1973 |
Experimental use of cytosine arabinoside in congenital cytomegalovirus infection.
Topics: Agranulocytosis; Cytarabine; Cytomegalovirus; Cytomegalovirus Infections; Female; Humans; Infant; Infant, Newborn; Male; Thrombocytopenia; Vomiting | 1972 |
Thrombocytopenia with sodium cephalothin therapy.
Topics: Agglutination Tests; Antibodies; Blood Cell Count; Blood Platelets; Cephalothin; Chromium Isotopes; Coombs Test; Cytarabine; Female; Gentamicins; Hemoglobins; Humans; Injections, Intravenous; Leukemia, Myeloid; Leukocyte Count; Middle Aged; Pneumonia; Polymyxins; Sodium; Thrombocytopenia | 1972 |
Cytosine arabinoside (NSC 63878) toxicity and antitumor acitivity in human solid tumors.
Topics: Adenocarcinoma; Anemia; Blood Cell Count; Blood Platelets; Bone Neoplasms; Breast Neoplasms; Cytarabine; Dose-Response Relationship, Drug; Female; Gastrointestinal Neoplasms; Hemoglobinometry; Humans; Injections, Intravenous; Leukopenia; Male; Nausea; Sarcoma; Thrombocytopenia; Vomiting | 1974 |
Daunorubicin. Results in childhood leukaemia.
Topics: Adolescent; Agranulocytosis; Anemia; Bone Marrow; Bone Marrow Cells; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Synergism; Female; Hemorrhage; Humans; Infant; Injections, Intravenous; Leukemia, Lymphoid; Leukemia, Myeloid; Male; Mercaptopurine; Neutrophils; Prednisolone; Thrombocytopenia; Vincristine | 1972 |
Daunorubicin in the therapy of acute granulocytic leukemia.
Topics: Adolescent; Adult; Age Factors; Aged; Blood Platelets; Blood Transfusion; Cytarabine; Daunorubicin; Female; Humans; Hydrazines; Hyperplasia; Leukemia, Myeloid; Leukocyte Count; Leukopenia; Male; Mercaptopurine; Methotrexate; Middle Aged; Remission, Spontaneous; Thrombocytopenia; Time Factors | 1973 |
Acute leukemia in adults.
Topics: Adult; Agranulocytosis; Antineoplastic Agents; Cytarabine; Drug Therapy, Combination; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Methotrexate; Prednisone; Thrombocytopenia; Time Factors | 1973 |
[Morphology of megakaryocytes in hematologic diseases].
Topics: Anemia, Pernicious; Blood Cell Count; Bone Marrow Cells; Cytarabine; Cytoplasm; Follow-Up Studies; Hematologic Diseases; Humans; In Vitro Techniques; Leukemia, Erythroblastic, Acute; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Megakaryocytes; Mercaptopurine; Plasmacytoma; Polycythemia; Thioguanine; Thrombocytopenia | 1974 |
Cytosine arabinoside and 6-thioguanine in refractory acute lymphocytic leukemia.
Topics: Adolescent; Age Factors; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Cytarabine; Drug Therapy, Combination; Female; Humans; Infant; Leukemia, Lymphoid; Leukopenia; Liver; Liver Function Tests; Male; Remission, Spontaneous; Thioguanine; Thrombocytopenia | 1974 |
Cytosine arabinoside as a single agent in the therapy of adult acute leukemia.
Topics: Administration, Oral; Adolescent; Adult; Age Factors; Aged; Anemia; Child; Cytarabine; DNA, Neoplasm; Female; Humans; Injections, Intravenous; Leukemia, Myeloid, Acute; Leukocytes; Male; Middle Aged; Muramidase; Nausea; Remission, Spontaneous; Sex Factors; Thioguanine; Thrombocytopenia; Time Factors; Vomiting | 1974 |
[Treatment of complications induced by chemotherapy of acute leukemias].
Topics: Agranulocytosis; Anemia, Aplastic; Anti-Bacterial Agents; Antineoplastic Agents; Asparaginase; Blood Platelets; Blood Transfusion; Cytarabine; Daunorubicin; Drug Therapy, Combination; Hemorrhage; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Leukocytes; Mercaptopurine; Methotrexate; Prednisone; Thrombocytopenia; Vincristine | 1974 |
Identification of circulating micromegakaryocytes in a case of refractory anemia: an electron microscopic-cytochemical study.
Topics: Adult; Alkaline Phosphatase; Anemia; Blood Cell Count; Blood Platelets; Bone Marrow Examination; Cytarabine; Daunorubicin; Female; Histocytochemistry; Humans; Megakaryocytes; Microscopy, Electron; Microscopy, Phase-Contrast; Peroxidases; Thrombocytopenia | 1972 |
Cytosine arabinoside (NSC-63878) in the treatment of epidermoid carcinomas of the head and neck.
Topics: Adult; Aged; Anemia; Blood Cell Count; Carcinoma, Squamous Cell; Cytarabine; Head; Head and Neck Neoplasms; Humans; Leukopenia; Liver Function Tests; Male; Middle Aged; Thrombocytopenia; Time Factors | 1971 |
[Cytosine arabinoside in the treatment of advanced lymphoblastic leukemia in children].
Topics: Adolescent; Anemia; Antineoplastic Agents; Child; Child, Preschool; Cytarabine; Humans; Infant; Infant, Newborn; Leukemia, Lymphoid; Thrombocytopenia | 1969 |
The treatment of acute lymphocytic leukemia.
Topics: Animals; Antineoplastic Agents; Asparaginase; Blood Platelets; Bone Marrow Cells; Cyclophosphamide; Cytarabine; Daunorubicin; Disease Models, Animal; Drug Synergism; Hemorrhage; Humans; Infections; Leukemia L1210; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Mercaptopurine; Methotrexate; Mice; Prednisone; Prognosis; Thrombocytopenia; Vincristine | 1970 |
Cytarabine.
Topics: Acute Disease; Amino Sugars; Anemia; Antibiotics, Antineoplastic; Antineoplastic Agents; Blood Cell Count; Cyclophosphamide; Cytarabine; Glycosides; Humans; Injections, Intravenous; Injections, Subcutaneous; Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukopenia; Lymphoma; Prednisone; Remission, Spontaneous; Thioguanine; Thrombocytopenia; Vincristine | 1971 |
Cytosine arabinoside in acute leukemia of childhood.
Topics: Child; Cytarabine; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Leukopenia; Remission, Spontaneous; Thrombocytopenia; Vomiting | 1971 |
[Experiences in the treatment of immature cell leukemias with cytosine arabinoside and daunorubidomycin].
Topics: Adolescent; Adult; Aged; Agranulocytosis; Allopurinol; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Blood Transfusion; Cytarabine; Humans; Leukemia; Leukemia, Erythroblastic, Acute; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Mercaptopurine; Methotrexate; Middle Aged; Muramidase; Nausea; Prednisolone; Thrombocytopenia; Vincristine | 1971 |